PIERIS PHARMACEUTICALS, INC. (Nasdaq:PIRS)

Health Care/Life Sciences • Biotechnology

CIK 1583648

Company

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.

Address
225 Franklin Street
9th floor
Boston, Massachusetts 02109

Employees
144

Stock Info

Close
$0.1720

Day Range
0.1709 - 0.1849

52 Week Range
0.1361 - 1.5200

Average volume
496.9K

Short Interest
66.22K (02/15/24)

% of Float Shorted
0.07%

Market Cap
$16.79M

Revenue
$25.9M

Net Income
-$33.28M

2020 Sales Growth
N/A

Rev. per Employee
$328.87K

P/E Ratio
N/A

EPS
-$0.3492

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Stephen S Yoder

Chairman
James Arthur Geraghty

Independent Director
Christopher P Kiritsy MBA

Independent Director
Peter Alec Kiener PhD

Independent Director
Maya R Said DSc

Independent Director
Matthew L Sherman MD

Independent Director
Ann Barbier MD, PhD

Independent Director
Michael S Richman

SEC filings

Date	Form	Event
14 Aug, 2024	10-Q
12 Aug, 2024	4
9 Aug, 2024	S-4
8 Aug, 2024	425
8 Aug, 2024	8-K
7 Aug, 2024	SCHEDULE 1
1 Aug, 2024	SC 13G
31 Jul, 2024	3
24 Jul, 2024	425
24 Jul, 2024	8-K
3 Jul, 2024	8-K
17 May, 2024	SC 13G
17 May, 2024	SC 13G
15 May, 2024	10-Q
9 May, 2024	8-K
29 Apr, 2024	10-K/A
18 Apr, 2024	8-K
29 Mar, 2024	10-K
27 Mar, 2024	8-K
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
2 Feb, 2024	SC 13G/A
21 Dec, 2023	8-K
14 Nov, 2023	10-Q
31 Aug, 2023	8-K/A
17 Aug, 2023	SC 13D/A
10 Aug, 2023	10-Q
10 Aug, 2023	S-8
18 Jul, 2023	8-K
13 Jul, 2023	8-K	CEO Change
26 Jun, 2023	8-K
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
23 Jun, 2023	4
21 Jun, 2023	8-K
12 Jun, 2023	SC 13G
8 Jun, 2023	8-K
30 May, 2023	4
22 May, 2023	SC 13D
22 May, 2023	3
19 May, 2023	8-K
11 May, 2023	10-Q
10 May, 2023	8-K
28 Apr, 2023	ARS
28 Apr, 2023	DEF 14A
28 Apr, 2023	DEFA14A
31 Mar, 2023	10-K
29 Mar, 2023	8-K
28 Feb, 2023	4
28 Feb, 2023	4
28 Feb, 2023	4
28 Feb, 2023	4
28 Feb, 2023	4
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
10 Feb, 2023	SC 13G/A
10 Feb, 2023	SC 13G/A
27 Jan, 2023	SC 13G
26 Jan, 2023	SC 13G/A
10 Jan, 2023	8-K
3 Jan, 2023	CT ORDER
3 Jan, 2023	CT ORDER
3 Jan, 2023	CT ORDER
16 Dec, 2022	CT ORDER
4 Nov, 2022	424B5
4 Nov, 2022	10-Q
4 Nov, 2022	8-K
2 Nov, 2022	8-K
1 Nov, 2022	8-K
24 Oct, 2022	SC 13G
13 Sep, 2022	8-K
4 Aug, 2022	S-8
4 Aug, 2022	10-Q
4 Aug, 2022	8-K
4 Aug, 2022	8-K
6 Jul, 2022	10-K/A
27 Jun, 2022	8-K
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
8 Jun, 2022	8-K
25 May, 2022	8-K
16 May, 2022	4
12 May, 2022	8-K/A
11 May, 2022	10-Q
11 May, 2022	8-K
29 Apr, 2022	DEFA14A
29 Apr, 2022	DEF 14A
2 Mar, 2022	10-K
1 Mar, 2022	8-K
24 Feb, 2022	4
24 Feb, 2022	4
24 Feb, 2022	4
24 Feb, 2022	4
24 Feb, 2022	4
24 Feb, 2022	4
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
14 Feb, 2022	SC 13G/A
27 Jan, 2022	SC 13G
24 Jan, 2022	8-K
14 Jan, 2022	8-K
14 Jan, 2022	8-K/A
3 Jan, 2022	8-K
18 Nov, 2021	8-K
2 Nov, 2021	10-Q
2 Nov, 2021	8-K
21 Oct, 2021	3
6 Oct, 2021	8-K
1 Sep, 2021	4
30 Aug, 2021	8-K
24 Aug, 2021	8-K
13 Aug, 2021	EFFECT
11 Aug, 2021	CORRESP
11 Aug, 2021	UPLOAD
5 Aug, 2021	10-Q
5 Aug, 2021	S-3
5 Aug, 2021	S-8
4 Aug, 2021	8-K
3 Aug, 2021	3
3 Aug, 2021	3
3 Aug, 2021	4
12 Jul, 2021	SC 13G/A
6 Jul, 2021	SC 13G
29 Jun, 2021	4
29 Jun, 2021	4
29 Jun, 2021	4
29 Jun, 2021	8-K
29 Jun, 2021	4
29 Jun, 2021	4
29 Jun, 2021	4
29 Jun, 2021	4
25 Jun, 2021	8-K
1 Jun, 2021	424B3
28 May, 2021	EFFECT
26 May, 2021	CORRESP
25 May, 2021	8-K
25 May, 2021	8-K
21 May, 2021	8-K
19 May, 2021	UPLOAD
17 May, 2021	10-Q
17 May, 2021	8-K
17 May, 2021	S-3
29 Apr, 2021	DEF 14A
29 Apr, 2021	DEFA14A
26 Apr, 2021	8-K
12 Apr, 2021	8-K
8 Apr, 2021	SC 13G
2 Apr, 2021	SC 13G
31 Mar, 2021	10-K
30 Mar, 2021	8-K
30 Mar, 2021	8-K
25 Mar, 2021	8-K
8 Mar, 2021	4
8 Mar, 2021	4
8 Mar, 2021	4
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G
12 Feb, 2021	SC 13G/A
29 Jan, 2021	SC 13G/A

Last update:2024-03-06 12:23:45.073301

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.